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RESEARCH ARTICLE
Effects of numerical information on intention to participate in cervical
screening among women offered HPV vaccination: a randomised study
Mie Sara Hestbecha, Dorte Gyrd-Hansenb, Jakob Kragstrupa, Volkert Siersmaa and John Brodersena,c
aThe Research Unit for General Practice and Section of General Practice, Department of Public Health, University of Copenhagen,
Copenhagen K, Denmark; bCOHERE, Department of Business and Economics and Department of Public Health, University of Southern
Denmark, Odense M, Denmark; cPrimary Health Care Research Unit, Zealand Region, Denmark
ABSTRACT
Objectives: To investigate the effects of different types of information about benefits and harms
of cervical screening on intention to participate in screening among women in the first cohorts
offered human papilloma virus (HPV) vaccination.
Design: Randomised survey study.
Setting: Denmark.
Subjects: A random sample of women from the birth cohorts 1993, 1994 and 1995 drawn from
the general population.
Interventions: A web-based questionnaire and information intervention. We randomised poten-
tial respondents to one of the following four different information modules about benefits and
harms of cervical screening: no information; non-numerical information; and two numerical infor-
mation modules. Moreover, we provided HPV-vaccinated women in one of the arms with numer-
ical information about benefits and harms in two steps: firstly, information without consideration
of HPV vaccination and subsequently information conditional on HPV vaccination.
Main outcome measure: Self-reported intention to participate in cervical screening.
Results: A significantly lower proportion intended to participate in screening in the two groups
of women receiving numerical information compared to controls with absolute differences of
10.5 (95% CI: 3.3–17.6) and 7.7 (95% CI: 0.4–14.9) percentage points, respectively. Among HPV-
vaccinated women, we found a significantly lower intention to participate in screening after
numerical information specific to vaccinated women (OR of 0.38).
Conclusions: Women are sensitive to numerical information about the benefits and harms of
cervical screening. Specifically, our results suggest that HPV-vaccinated women are sensitive to
information about the expected changes in benefits and harms of cervical screening after imple-
mentation of HPV vaccination.
KEY POINTS
 Women were less likely to participate in cervical screening when they received numerical
information about benefits and harms compared to non-numerical or no information.
 Specifically, numerical information about the potential impact of the reduced risk of cervical
cancer among HPV-vaccinated women reduced the intention to participate among vaccinated
women.
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Women in several countries will soon be covered by
two preventive programmes targeting cervical cancer:
HPV vaccination and cervical screening. Screening for
cervical cancer has been followed by a reduction in
incidence and mortality, which is assumed to be
largely attributable to the screening.[1] However,
screening also leads to unintended harms such as
false-positive results, overdiagnosis and overtreat-
ment.[2] HPV vaccines prevent infection with HPV
types 16 and 18, which are responsible for approxi-
mately 70% of cervical cancers and have proven to be
highly efficacious on precursors of cancer.[3] Thus,
women vaccinated against HPV before, or near, sexual
debut, are expected to have a substantially reduced
risk of cervical cancer. When the incidence of a condi-
tion screened for decreases, the benefits and harms
also decrease, but the benefits are likely to decrease
more than the harms.[4] Therefore, the premises on
CONTACT Mie Sara Hestbech mie.hestbech@sund.ku.dk The Research Unit for General Practice and Section of General Practice, Department of
Public Health, University of Copenhagen, Øster Farimagsgade 5, Copenhagen K, 1014, Denmark 2099
 2016 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative
Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction
in any medium, provided the original work is properly cited.
SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2016
VOL. 34, NO. 4, 401–419
http://dx.doi.org/10.1080/02813432.2016.1249056
which these women decide about participation in cer-
vical screening have changed.
Patient-centred care is a cornerstone in modern
health care,[5] and in the context of cancer screening
programmes, informed choice is crucial.[6] The general
practitioner (GP) plays a central role in this. Previous
studies have shown that women’s knowledge about
cervical cancer is generally poor and that they over-
estimate their risk of cervical cancer and the effect of
cervical screening.[7–10] Providing the information
needed for an informed choice may be difficult for the
GP, especially after the introduction of HPV vaccin-
ation. Most information material is non-numerical.[11]
This may be justified, since previous research indicates
that people can have difficulty deriving meaning from
numerical risk communication.[12,13] However, we
need to study how different types of information
affect patients.[14]
The purpose of this study was to investigate the
effect of different types of information about benefits
and harms on intention to participate in cervical
screening among women in the first cohorts offered
HPV vaccination. Firstly, we aimed to investigate
whether informing women numerically about benefits
and harms would have an impact on their intention to
participate in screening. Secondly, we aimed to investi-
gate whether informing vaccinated women about vac-
cination related change in benefits and harms would
impact their intention to participate.
Methods
Setting
The Danish Health Authority recommends cytology
screening every 3 years from the age of 23 and every
5 years for 50–64-year olds. Screening samples are
taken free of charge by GPs. From 1 October 2008,
Danish women born 1993–1995 were offered free HPV
vaccination in a catch-up programme, and from 1
January 2009, free vaccination was offered to all girls
turning 12 years as part of the national childhood
immunisation programme. Approximately, 80% of
these birth cohorts have received all recommended
doses of the vaccine.[15] The first women vaccinated
below the age of 16 (in the catch-up programme) will
enter the cervical screening programme from 2016
and onwards.
Trial design
We performed an online survey where the sampled
women were randomised to four arms with an
allocation ratio of 1:1:1:1 before distribution of the
invitations.
Population and procedure
The study population was Danish women from the
birth cohorts 1993, 1994 and 1995. A random sample
of women in these cohorts was drawn from the total
Danish female population using the Danish Civil
Registration System (CRS). We received personal con-
tact information drawn from public registers.
Telephone numbers were matched on name and
address. We excluded those who did not have a pub-
licly registered telephone number. We sent a small
text message (SMS) containing a link to the survey to
the remaining potential respondents. No gifts, prizes
or other incentives were used. Data collection started
8 April 2015. Reminders were sent 8 days and 14 days
after data collection started. The data collection ended
20 May 2015 when no further responses had been
received for more than two weeks.
Survey data were supplemented with socio-demo-
graphic data obtained from Statistics Denmark. The
CRS contains information on all individuals with a
permanent address in Denmark.[16] CPR-numbers (a
unique personal identification number) were used to
link each potential respondent to data from registers
in Statistics Denmark. We included the following var-
iables: ethnicity, degree of urbanisation in area of
habitat, completed educational level, parents’ educa-
tional level and primary care contacts within the
previous year. Since the study population was
women aged 19–22 years, many of whom will not
have finished their education, we obtained data
about educational level from both the potential
respondent and the respondents’ parents. Moreover,
we asked respondents about their on-going educa-
tion in the questionnaire. Number of contacts with
the primary care sector within the last year was
interpreted as an indicator of the intensity of health
care services use.
Randomisation
A computer-generated code that randomly assigned
the population numbers specifying study arm was
applied to the study population by a data manager
who was not otherwise involved in the project. Links
to questionnaires were sent directly and automatically
to the potential respondents, who were blinded to the
fact that they received one out of four different infor-
mation interventions.
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Questionnaire and intervention
We developed a web-based questionnaire that was
programmed in SurveyXact and compatible with
smartphones and tablets. Potential respondents
received an invitation by SMS. The SMS contained a
direct link to the questionnaire, which consisted of
two parts: The first part was identical for all respond-
ents. The second part contained one of the four infor-
mation interventions and the outcome assessment.
In the first part of the questionnaire, respondents
were asked about their completed and on-going edu-
cation and HPV vaccination status.
In the second part of the questionnaire, all potential
respondents were randomised to one of four arms.
Outcomes were assessed after the information
intervention.
We randomised women to receive one of the fol-
lowing four information modules (Figure 1):
1. No information/controls: No information about
benefits and harms of cervical screening.
2. Non-numerical information/basic information mod-
ule: Non-numerical information about benefits and
harms of cervical screening: treatment of severe
abnormalities (conisation), side-effects of conisa-
tion, the beneficial effect of screening, false-nega-
tive and false-positive results and overdiagnosis.
The concepts were described, but not quantified.
3. Numerical information based on unvaccinated
population: The basic information module as
described above was supplemented with numer-
ical information for an unvaccinated population
about benefits and harms of cervical screening.
Random sample of 
women (born 1993-
95)
First common part 
of quesonnaire
Arm 1
No informaon
Parcipate in 
screening?
Arm 2
Non-numerical
informaon
Parcipate in 
screening?
Arm 3
Numerical (without 
HPV vaccinaon)
Parcipate in 
screening?
Only HPV 
vaccinees: 
Numerical (with 
HPV vaccinaon)
Parcipate in 
screening?
Arm 4
Numerical
(personalised to 
HPV vacc status)
Parcipate in 
screening?
Figure 1. Study design.
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4. Numerical information personalised to HPV vaccin-
ation status: The same information as in module 3
for unvaccinated women, but the vaccinated
women received information about expected ben-
efits and harms for HPV-vaccinated women.
The effect of the information format was studied by
comparing the four arms. An addition was made to
study arm 3 for HPV-vaccinated women only: after the
first outcome assessment the HPV-vaccinated respond-
ents were presented with expected benefits and harms
for vaccinated women. The new information was pre-
sented in a table together with the numbers pertain-
ing to unvaccinated women, so comparisons could be
made, and the respondents were asked to reassess
their intention to participate in screening. The reason
for this two-step design was to supplement the prior
measure of inter-respondent effect of information with
a measure of intra-respondent effect.
We created the non-numerical parts of the informa-
tion modules with the national information folder
from the Danish Health Authority as a template.[17]
We shortened and condensed the text in order to fit
the web-based format.
The numerical information was based on best avail-
able evidence for benefits and harms of cervical screen-
ing: To quantify the beneficial effect of cervical
screening, we calculated number of cervical cancer
cases prevented based on a systematic literature review
and meta-analysis of the effect of cervical screening on
cervical cancer incidence and mortality.[1] To our know-
ledge, no meta-analysis of all harmful effects of cervical
screening exists. Therefore, our quantifications of harms
were based on a small number of single studies.[17–19]
Estimates of effects of cervical screening for HPV-vacci-
nated women were calculated based on RCTs of the
quadrivalent HPV vaccination on cervical disease.[20]
All quantitative information was presented based on
evidence-based principles of risk communication [21]:
Estimates of beneficial and harmful effects were pre-
sented as natural frequencies using the same denomin-
ator of 1000 women and risk reductions were
presented as absolute risk reductions (ARR).
The first draft of questionnaire items and informa-
tion modules was the product of an iterative process
involving consecutive discussions in the group of
authors. The final formulation was made through pilot
testing in the form of qualitative interviews with 12
women in the target group. A combination of two
techniques was applied: Think-aloud interviewing and
cognitive probing.[22] During the process, the question-
naire was validated for content validity (translated ver-
sion of questionnaire provided in Appendix).
Outcomes
The primary outcome was intention to participate in
cervical screening, which we used as a measure of sensi-
tivity to information. This is an accepted outcome meas-
ure that has previously been used in the context of
cervical screening.[23] The question “Do you think that
you will attend cervical screening?” had three response
options: “Yes”, “no” and “I do not know”. The secondary
outcome was certainty with the decision whether to
participate in screening assessed on an ordinal scale
with the response options: “certain”; “a little unsure”;
“unsure” and “I do not know”. The secondary outcome
was assessed among respondents who declared inten-
tion to participate as well as those who declared inten-
tion not to participate. We had no a priori hypothesis as
to in what direction information would affect self-rated
certainty with the decision to attend screening. We
speculated that information could either increase cer-
tainty by clarifying unanswered questions, or decrease
certainty because it conflicted with preconceptions.
Statistical analyses
We compared the proportion of women who
responded “yes” to the question of whether they
intended to participate in cervical screening between
the four study arms. In our sensitivity analyses of the
primary outcome, we repeated the analyses excluding
all women who had responded “I do not know” to this
question. Moreover, we repeated the analyses group-
ing together the responses “I do not know” and “yes”
to this question. Only the outcome assessment after
the first information step in study arm 3 was included
in the analyses. HPV-vaccinated and non-vaccinated
women were included in all study arms.
In an intra-respondent analysis within study arm 3,
we compared (i) intention to participate in screening
after receiving numerical information about screening
of women without HPV vaccination with (ii) intention to
participate after additionally having received numerical
information about screening of women with HPV vac-
cination. Only HPV-vaccinated respondents were
included in the analysis, as the second information step
was only provided to this subgroup. We conducted the
same sensitivity analyses as described earlier.
We performed only pre-specified analyses. All inter-
respondent analyses between groups were done using
chi-squared tests. We tested whether the effect of dif-
ferential information on the intention to participate in
screening was dependent on vaccination status in a
logistic regression model with an interaction between
HPV vaccination status and study arm. The intra-
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respondent comparison in study arm 3 was done with
logistic regression analysis, adjusting for repeated
measurements with Generalised Estimating Equations.
The level of statistical significance was set to 5%. All cal-
culations were made in SAS v9.4 (SAS Institute Inc.,
Cary, NC).
A power calculation was conducted to determine
the appropriate sample size to test the hypothesis that
exposure to numerical information would result in a
changed proportion of women intending to participate
in screening. To detect a difference of at least 10 per-
centage points between different arms with 80%
power, the required sample size was 200 in each arm,
or 800 in total.
Results
Participant flow and recruitment
In the random sample of 4455 women, 3293 (73.9%)
had a publicly registered telephone number and were
sent a link to the survey. The overall response rate was
30.0% (22.2% among initial sample) (n¼ 988), and
25.0% (n¼ 823) completed all parts of their question-
naire. We received 26 e-mails from potential respond-
ents, who had received an SMS but were not in the
target group (male sex, older age group). Eleven of
these 26 persons had responded to the questionnaire
and their responses were excluded from analyses, leav-
ing 977 (29.7%) responders to be included in the analy-
ses (Figure 2).
Sociodemographic characteristics and dropout
analyses
Dropout analyses revealed differences between
women with no available telephone number, non-
respondents and respondents. Relative to non-
respondents and women with no available telephone
number respondents were more frequently ethnic
Danes, had more primary-care contacts in the previous
year and were more likely to have more than primary
education (þ 9 years of schooling), as were their
parents. Respondents and women with no available
telephone number more often than non-respondents
lived in a densely populated area. Respondents (com-
plete as well as partial respondents) were equally dis-
tributed between study arms. Furthermore,
sociodemographic analysis revealed no statistically sig-
nificant differences between study arms (Table 1).
Primary outcome
Overall, 81.6% of women in our sample intended to
participate in cervical screening. In Table 2, screening
intentions are listed by HPV vaccination status for
each study arm and for the total population. The pro-
portion of women who intended to participate in
screening was larger among HPV-vaccinated women
than among non-vaccinated women. This pattern was
consistent across all study arms. The effect of differen-
tial information was not dependent on HPV vaccin-
ation status (p¼ .435 of the interaction between study
arm and HPV vaccination status).
In our cross-sectional analysis, we found a signifi-
cantly lower proportion of women intending to partici-
pate in screening in the two groups receiving
numerical information (arms 3 and 4) compared to
controls (arm 1), who received no information. The
absolute difference was 10.5% points (77.0% in arm 3
vs. 87.4% in arm 1) and 7.7% points (79.8% in arm 4
vs. 87.4% in arm 1). We found no statistically signifi-
cant differences between any of the other arms. In our
sensitivity analyses, the difference between arm 4 and
controls became non-significant, while the difference
between arm 3 and controls remained statistically sig-
nificant (Table 3).
In our intra-respondent analysis of HPV-vaccinated
women in study arm 3, we found a statistically sig-
nificant effect of vaccination-specific information.
After receiving information about benefits and harms
for non-vaccinated women 83.9% (n¼ 141/168)
intended to participate in screening, but only 66.5%
(n¼ 112/164) intended to participate after receiving
information personalised to vaccinated women. This
corresponds to an OR of 0.38 for intention to par-
ticipate in screening (95% CI: 0.26–0.56), p< .0001. In
our sensitivity analyses, in which the “I do not
know” responses were excluded or grouped with the
“yes” responses, this difference became non-signifi-
cant. This reflects that the majority of HPV-vacci-
nated women, who shifted their response when
presented with the additional information on screen-
ing outcomes, changed their response, from “yes” to
“I do not know”.
Secondary outcome
Generally, the majority of respondents across study
arms (70.2%) reported being “certain” with their
answer to the question regarding whether to intend
to participate in screening. We found a statistically sig-
nificant difference (p¼ .04) between study arms, as
fewer women in the two arms receiving numerical
information reported being certain with their answer
(76.7% in arm 1 vs. 74.0% in arm 2 vs. 66.5% in arm 3
vs. 62.9% in arm 4).
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Discussion
In summary, fewer women wanted to be screened
when they received numerical information about ben-
efits and harms of screening. Fewer HPV-vaccinated
women wanted to be screened when they received
numerical information about benefits and harms with
HPV vaccination, compared to without HPV
vaccination.
The major strength of this study is the randomised
design, which eliminates confounding. The four study
arms allowed inter- and intra-respondent comparisons,
and we found a significant intra-respondent effect in
study arm 3. This was found despite an expected
“anchoring effect”, which might reduce the effect of
the second information intervention, because people
have a tendency to hold on to their first decision
when subsequently confronted with a similar ques-
tion.[24] Moreover, the questionnaire and the informa-
tion modules used in the study were thoroughly
validated in qualitative interviews, and we used a
Figure 2. Flow diagram of participants.
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random population sample. There are limitations to
the study. Firstly, the response rate of 29.7% is low.
This is to be expected as the age group is considered
a “hard-to-reach” group in the context of survey
research. Dropout analyses reveal that the sample was
not entirely representative, as we found sociodemo-
graphic participation bias: respondents seem to come
from better educated families and have had more con-
tact with the primary care sector. However, more
importantly, there were no sociodemographic differen-
ces between randomisation groups. One might ques-
tion our use of smartphones via an SMS link as
administration form. But studies have shown that the
use of PDA (personal digital assistant), which is com-
parable to – and now replaced by – a modern smart-
phone, as administration method is non-inferior to
other more commonly used methods in survey
research.[25,26] Since the target group of this survey is
young women who are generally very familiar with
the use of smartphones,[27] we believe that our
method of administration is a strength of this study.
Finally, it can be argued that intention to participate
in screening is not an optimal primary outcome.
Actual participation is a more reproducible outcome,
but also affected by many different exogenous factors,
while intention to participate is an instant measure of
sensitivity to information. Ideally one would want to
measure informed choice, but this is difficult to
measure.[28]
Our finding is in line with previous studies that
have demonstrated that evidence-based information
about cervical screening decreases intention to partici-
pate,[23,29] but conflicts with studies suggesting that
lay people may not understand quantitative risk com-
munication [12,13] and are not sensitive to communi-
cation about benefits and harms of screening.[30]
Those who changed their intentions in our study
might reflect a subset of women who are better at
processing complex numerical information. Therefore,
we recognise the need for further research in risk com-
munication strategies. In our inter-respondent analysis
and our cross-sectional analysis of study arm 3, the dif-
ference in intention to participate in screening is
driven by a large proportion of women changing their
response from “yes” to “I do not know”. This could
possibly indicate that the information caused some
confusion, maybe because the quantity of information
was overwhelming for some. Analysis of our secondary
outcome supports this interpretation, since we find
that self-rated certainty with the screening decision is
lower in the two arms provided with numerical infor-
mation. On the other hand, uncertainty could also be
a rational response to a choice with a fine balance
between benefits and harms. That written numerical
information generates uncertainty amongst some
might signify the importance of additional information
provided in a different way, this could be verbal infor-
mation from the GP.
This study emphasises the importance of complete
information about benefits and harms in cervical
screening. In addition, it suggests that HPV-vaccinated
women should be numerically informed about the
new premises of cervical screening because the
Table 2. Screening intentions by study arm and HPV vaccination status.
Study arm 1
n (%)
Study arm 2
n (%)
Study arm 3a
n (%)
Study arm 4
n (%)
Total
N (%)
p value
(HPVastudy arm)b
Total n in group
included in ana-
lysis (n/n/n/n)
Total n in group 250 254 245 228 977
HPV vaccinated
Intend to participate in screening
Yes
No
Do not know
150 (90.4)
3 (1.8)
13 (7.8)
149 (89.2)
6 (3.6)
12 (7.2)
141 (83.9)
5 (3.0)
22 (13.1)
122 (84.7)
6 (4.2)
16 (11.1)
562 (87.1)
20 (3.1)
63 (9.8)
166/
167/
168/
144
Not HPV vaccinated
Intend to participate in screening
Yes
No
Do not know
38 (77.5)
6 (12.2)
5 (10.2)
30 (57.7)
14 (26.9)
8 (15.4)
23 (51.1)
12 (26.7)
10 (22.2)
28 (63.6)
12 (27.3)
4 (9.1)
119 (62.6)
44 (23.2)
27 (14.2)
49/
52/
45/
44
All
Intend to participate in screening
Yes
No
Do not know
188 (87.4)
9 (4.2)
18 (8.4)
179 (81.7)
20 (9.1)
20 (9.1)
164 (77.0)
17 (8.0)
32 (15.0)
150 (79.8)
18 (9.6)
20 (10.6)
681 (81.6)
64 (7.7)
80 (10.8)
0.435
215/
219/
213/
188
aAfter first information step.
bLogistic regression analysis. Outcome: Intention to participate in screening. Explanatory variables: Study arm and HPV vaccination status. p value for
interaction HPV vaccination statusstudy arm.
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information might be important to their decision
whether or not to attend screening. The intention to
participate varied from 51% to 89% depending on
HPV vaccination status and type of information pro-
vided. However, the benefits and harms of cervical
screening after implementation of HPV vaccination
must be investigated further, to guide information
material as well as decisions about whether to make
reforms to the existing screening programmes.
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Table 3. Absolute differences in primary outcome between the study groups.
Study arm 1
No information/
controls
Study arm 2
Non-numerical
information/
basic
information
module
Study arm 3a
Numerical information
based on data
without HPV vacccine.
Study arm 4
Numerical information
personalised
to HPV
vaccination status
Intend to participate in screening (yes vs. no/I do not know) (n/n) (%) 188/27
87.4%
179/40
81.7%
164/49
77.0%
150/38
79.8%
Absolute difference from study arm 1, percentage points (95% CI)
Primary analysis
(yes vs. no/I do not know)
– 25.7
(212.5 to 1.1)
N.S.
210.5
(217.6 to 23.3)
(p5 .005)
27.7
(214.9 to 20.4)
(p5 .037)
Sensitivity analysis
(yes vs. no)
– 25.5
(20.4 to 210.6)
(p¼ .036)
24.8
(210.0 to 0.3)
N.S.
26.2
(211.7 to 20.6)
(p¼ .025)
Sensitivity analysis
(yes/I do not know vs. no)
– 25.0
(29.6 to 0.3)
(p¼ .039)
23.8
(28.3 to 0.7)
N.S.
25.4
(210.4 to 0.4)
(p¼ .031)
Absolute difference from study arm 2, percentage points (95% CI)
Primary analysis
(yes vs. no/I do not know)
5.7
(21.1 to 12.5)
N.S.
– 24.7
(212.4 to 2.9)
N.S.
22.0
(29.6 to 5.7)
N.S.
Sensitivity analysis
(yes vs. no)
5.5
(0.4–10.6)
(p¼ .036)
– 20.7
(26.6 to 5.3)
N.S.
20.7
(26.9 to 5.6)
N.S.
Sensitivity analysis
(yes/I do not know vs. no)
5.0
(0.3–9.6)
(p¼ .039)
– 21.2
(26.4 to 4.1)
N.S.
20.4
(26.1 to 5.2)
N.S.
Absolute difference from study arm 3, percentage points (95% CI)
Primary analysis
(yes vs. no/I do not know)
10.5
(3.3–17.6)
(p5 .005)
4.7
(22.9 to 12.4)
N.S.
– 2.8
(25.3 to 10.9)
N.S.
Sensitivity analysis
(yes vs. no)
4.8
(0.3–10.0)
N.S.
0.7
(25.3 to 6.6)
N.S.
– 1.3
(25.0 to 7.6)
N.S.
Sensitivity analysis
(yes/I do not know vs. no)
3.8
(20.7 to 8.3)
N.S.
1.2
(24.1 to 6.4)
N.S.
– 21.6
(27.2 to 4.0)
N.S.
Absolute difference from study arm 4, percentage points (95% CI)
Primary analysis
(yes vs. no/I do not know)
7.7
(0.4–14.9)
(p5 .037)
2.0
(25.7 to 9.6)
N.S.
22.8
(210.9 to 5.3)
N.S.
–
Sensitivity analysis
(yes vs. no)
6.2
(0.6–11.7)
(p¼ .025)
0.7
(25.6 to 6.9)
N.S.
21.3
(27.6 to 5.0)
N.S.
–
Sensitivity analysis
(yes/I do not know vs. no)
5.4
(0.4–10.4)
(p¼ .031)
0.4
(25.2 to 6.1)
N.S.
1.6
(24.0 to 7.2)
N.S.
–
aAfter first information step.
Primary analyses are in bold text.
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